Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Synovial 1 Sarcoma 1 Neurofibrosarcoma 1 Melanoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Dermatofibrosarcoma 1 Carcinoma, Basal Cell 1

Interventions

Nivolumab 7 cemiplimab 6 Specimen Handling 5 HhAntag691 5 Radiotherapy 4 Magnetic Resonance Spectroscopy 4 Ipilimumab 4 Biopsy 4 sonidegib 3 pembrolizumab 3 CTLA-4 Antigen 3 relatlimab 2 prednylidene 2 deltacortene 2 daromun 2 Surgical Procedures, Operative 2 Standard of Care 2 Prednisone 2 Observation 2 Aminolevulinic Acid 2 tocilizumab 1 talimogene laherparepvec 1 poly ICLC 1 flt3 ligand protein 1 X-Rays 1 Watchful Waiting 1 Vitamin D 1 Tomography, Optical Coherence 1 Therapeutics 1 Tacrolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Basal Cell × BO-112 × 1 year × Clear all

NCT06422936 2026-01-26

SPOTLIGHT204

Highlight Therapeutics

Phase 2 Active not recruiting

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡